2006;354:209 10. S7.8-6. Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250 60. S7.8-7. Van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med. 2005;83:79 83. S7.8-8. Russo V, Nigro G. ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial func- tion: 2013 ESC guidelines on cardiac pacing and cardiac resynchro- nization therapy. Europace. 2015;17:337. S7.8-9. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormali- ties and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008;358:2688 97. S7.8-10. Lallemand B, Clementy N, Bernard-Brunet A, et al. The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications. Heart. 2012;98:291 6. S7.8-11. Nazarian S, Wagner KR, Caffo BS, et al. Clinical predictors of con- duction disease progression in type I myotonic muscular dystrophy. Pacing Clin Electrophysiol. 2011;34:171 6. S7.8-12. Tanawuttiwat T, Wagner KR, Tomaselli G, et al. Left ventricular dys- function and conduction disturbances in patients with myotonic muscular dystrophy type I and II. JAMA Cardiology. 2017;2:225 8. S7.8-13. Bhakta D, Shen C, Kron J, et al. Pacemaker and implantable cardio- verter-defibrillator use in a US myotonic dystrophy type 1 popula- tion. J Cardiovasc Electrophysiol. 2011;22:1369 75. S7.8-14. Laurent V, Pellieux S, Corcia P, et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol. 2011;150:54 8. S7.8-15. Groh WJ. Arrhythmias in the muscular dystrophies. Heart Rhythm. 2012;9:1890 5. S7.8-16. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 